These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35625557)

  • 21. Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from alpha-synuclein mutants.
    van Raaij ME; Segers-Nolten IM; Subramaniam V
    Biophys J; 2006 Dec; 91(11):L96-8. PubMed ID: 16997873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy.
    Li Y; Zhao C; Luo F; Liu Z; Gui X; Luo Z; Zhang X; Li D; Liu C; Li X
    Cell Res; 2018 Sep; 28(9):897-903. PubMed ID: 30065316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase.
    Azevedo EP; Guimarães-Costa AB; Torezani GS; Braga CA; Palhano FL; Kelly JW; Saraiva EM; Foguel D
    J Biol Chem; 2012 Oct; 287(44):37206-18. PubMed ID: 22918834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic insight into the relationship between N-terminal acetylation of α-synuclein and fibril formation rates by NMR and fluorescence.
    Kang L; Janowska MK; Moriarty GM; Baum J
    PLoS One; 2013; 8(9):e75018. PubMed ID: 24058647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils.
    Yang X; Wang B; Hoop CL; Williams JK; Baum J
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs.
    Boyer DR; Li B; Sun C; Fan W; Sawaya MR; Jiang L; Eisenberg DS
    Nat Struct Mol Biol; 2019 Nov; 26(11):1044-1052. PubMed ID: 31695184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atomic force microscopy under controlled conditions reveals structure of C-terminal region of α-synuclein in amyloid fibrils.
    Sweers KK; van der Werf KO; Bennink ML; Subramaniam V
    ACS Nano; 2012 Jul; 6(7):5952-60. PubMed ID: 22695112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.
    Flagmeier P; Meisl G; Vendruscolo M; Knowles TP; Dobson CM; Buell AK; Galvagnion C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10328-33. PubMed ID: 27573854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases.
    Yagi H; Kusaka E; Hongo K; Mizobata T; Kawata Y
    J Biol Chem; 2005 Nov; 280(46):38609-16. PubMed ID: 16162499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.
    Cohlberg JA; Li J; Uversky VN; Fink AL
    Biochemistry; 2002 Feb; 41(5):1502-11. PubMed ID: 11814343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Properties of α-Synuclein Secondary Nuclei Are Dominated by the Solution Conditions Rather than the Seed Fibril Strain.
    Peduzzo A; Linse S; Buell AK
    ACS Chem Neurosci; 2020 Mar; 11(6):909-918. PubMed ID: 32069013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation Effects of Fe
    Li Y; Yu Y; Ma G
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity.
    Murata T; Tochio N; Utsunomiya-Tate N
    Neurosci Lett; 2021 Aug; 760():136077. PubMed ID: 34161822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure.
    Zhao K; Li Y; Liu Z; Long H; Zhao C; Luo F; Sun Y; Tao Y; Su XD; Li D; Li X; Liu C
    Nat Commun; 2020 May; 11(1):2643. PubMed ID: 32457390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.
    Coskuner O; Wise-Scira O
    ACS Chem Neurosci; 2013 Jul; 4(7):1101-13. PubMed ID: 23607785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of α-synuclein.
    Ohgita T; Namba N; Kono H; Shimanouchi T; Saito H
    Sci Rep; 2022 Apr; 12(1):6770. PubMed ID: 35474118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.
    Conway KA; Lee SJ; Rochet JC; Ding TT; Williamson RE; Lansbury PT
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):571-6. PubMed ID: 10639120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Synuclein aggregation at low concentrations.
    Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorph-specific distribution of binding sites determines thioflavin-T fluorescence intensity in α-synuclein fibrils.
    Sidhu A; Vaneyck J; Blum C; Segers-Nolten I; Subramaniam V
    Amyloid; 2018 Sep; 25(3):189-196. PubMed ID: 30486688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.